Hematopoietic and Lymphoid Cell Disorder clinical trials
17 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
- Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
- Hematology Biobank: In Vitro Study of Blood Disorders
- Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
- Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
- Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
- ATHNdataset Registry
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- HEME Home Transfusion Program
- Health-Related Social Needs Food Boxes Delivery Program
- Enteral Nutrition Versus Standard of Care in Allogeneic Hematopoietic Stem Cell Transplantation
- Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors
- Bone Marrow Grafting for Leukemia and Lymphoma
- Screening for Hematology Branch Protocols
- Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Hematopoietic and Lymphoid Cell Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.